Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)

Abroad (travel likely)Recruiting

Conditions

Coronary Heart Disease (CHD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Beijing Luhe Hospital, Beijing, Beijing Municipality, China

  • The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China

  • The 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

  • The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

  • Heze Municipal Hospital, Heze, Shandong, China

  • Shandong Provincial Hospital, Jinan, Shandong, China

  • Shandong Provincial Third Hospital, Jinan, Shandong, China

    Contact: Study coordinator (Wei Zhou) · zhouguo321@126.com · + 86 15853166471
  • Affiliated Hospital of Jining Medical University, Jining, Shandong, China

    Contact: Study coordinator (Lijun Gan) · 13792336453@163.com
  • Liaocheng People's Hospital, Liaocheng, Shandong, China

  • Qingdao Municipal Hospital, Qingdao, Shandong, China

    Contact: Study coordinator (Wei Xia) · 18669710958@163.com · +86 18669710958
  • Tai'an City Central Hospital, Tai’an, Shandong, China

  • Zaozhuang Municipal Hospital, Zaozhuang, Shandong, China

  • Shanghai Fengxian District People's Hospital, Shanghai, Shanghai Municipality, China

  • The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang, China